FR2792837B1 - Medicaments utiles pour le traitement des troubles de la regulation de la masse adipeuse et des maladies associees aux troubles de la production de leptine - Google Patents

Medicaments utiles pour le traitement des troubles de la regulation de la masse adipeuse et des maladies associees aux troubles de la production de leptine

Info

Publication number: FR2792837B1
Authority: FR; France
Prior art keywords: disorders; treatment; diseases associated; adipose mass; leptin production
Prior art date: 1999-04-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

FR9905450A

Other languages

English (en)

Other versions

FR2792837A1 (fr

Inventor

Cinderella Gerhardt

Romero Ignacio Andres Romero

Arthur Donny Strosberg

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Centre National de la Recherche Scientifique CNRS

Original Assignee

Centre National de la Recherche Scientifique CNRS

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-29

Filing date

1999-04-29

Publication date

2001-07-13

1999-04-29 Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS

1999-04-29 Priority to FR9905450A priority Critical patent/FR2792837B1/fr

2000-04-28 Priority to PCT/FR2000/001171 priority patent/WO2000066149A1/fr

2000-11-03 Publication of FR2792837A1 publication Critical patent/FR2792837A1/fr

2001-07-13 Application granted granted Critical

2001-07-13 Publication of FR2792837B1 publication Critical patent/FR2792837B1/fr

2019-04-29 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 3
102000016267 Leptin Human genes 0.000 title 1
108010092277 Leptin Proteins 0.000 title 1
201000010099 disease Diseases 0.000 title 1
239000003814 drug Substances 0.000 title 1
NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 title 1
229940039781 leptin Drugs 0.000 title 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6869—Interleukin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Hematology (AREA)
General Health & Medical Sciences (AREA)
Diabetes (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Obesity (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Endocrinology (AREA)
Biomedical Technology (AREA)
Reproductive Health (AREA)
Cell Biology (AREA)
Urology & Nephrology (AREA)
Food Science & Technology (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Child & Adolescent Psychology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biotechnology (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

FR9905450A 1999-04-29 1999-04-29 Medicaments utiles pour le traitement des troubles de la regulation de la masse adipeuse et des maladies associees aux troubles de la production de leptine Expired - Lifetime FR2792837B1 (fr)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
FR9905450A FR2792837B1 (fr)	1999-04-29	1999-04-29	Medicaments utiles pour le traitement des troubles de la regulation de la masse adipeuse et des maladies associees aux troubles de la production de leptine
PCT/FR2000/001171 WO2000066149A1 (fr)	1999-04-29	2000-04-28	Medicaments utiles pour le traitement des troubles de la regulation de la masse adipeuse et des maladies associees aux troubles de la production de leptine

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9905450A FR2792837B1 (fr)	1999-04-29	1999-04-29	Medicaments utiles pour le traitement des troubles de la regulation de la masse adipeuse et des maladies associees aux troubles de la production de leptine

Publications (2)

Publication Number	Publication Date
FR2792837A1 FR2792837A1 (fr)	2000-11-03
FR2792837B1 true FR2792837B1 (fr)	2001-07-13

Family

ID=9545027

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR9905450A Expired - Lifetime FR2792837B1 (fr)	1999-04-29	1999-04-29	Medicaments utiles pour le traitement des troubles de la regulation de la masse adipeuse et des maladies associees aux troubles de la production de leptine

Country Status (2)

Country	Link
FR (1)	FR2792837B1 (fr)
WO (1)	WO2000066149A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA3081071A1 (fr)	2002-10-16	2004-04-29	Gen-Probe Incorporated	Compositions et methodes de detection du virus du nil occidental
US7927840B2 (en)	2006-09-11	2011-04-19	Gen Probe Incorporated	Method for detecting West Nile Virus nucleic acids in the 3′ non-coding region
CN101005855A (zh) *	2004-07-30	2007-07-25	辉瑞产品公司	治疗由ccr2介导的疾病或紊乱的方法
WO2018209359A1 (fr)	2017-05-12	2018-11-15	President And Fellows Of Harvard College	Administration systémique de polypeptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0897980A3 (fr) *	1997-08-20	2002-04-17	Smithkline Beecham Corporation	CXCR4B: Un variant d'épissage humain du récepteur de chemokine CXCR4

1999
- 1999-04-29 FR FR9905450A patent/FR2792837B1/fr not_active Expired - Lifetime
2000
- 2000-04-28 WO PCT/FR2000/001171 patent/WO2000066149A1/fr active Application Filing

Also Published As

Publication number	Publication date
WO2000066149A1 (fr)	2000-11-09
FR2792837A1 (fr)	2000-11-03

Similar Documents

Publication	Publication Date	Title
FR13C0060I2 (fr)	2014-04-11	Omega-carboxyaryldiphenyluree fluoro-subtituee pour le traitement et la prevention de maladies et d'etats pathologiques
EP0788359A4 (fr)	1998-08-19	Compositions utiles a la preparation de medicaments destines au traitement de divers troubles refractaires
HUP9700603A3 (en)	2001-08-28	Pharmaceutical preparation for the treatment of blood coagulation disorders
EE200200274A (et)	2003-06-16	Pürrolidiinatseetamiidi derivaadi kasutamine ravimi valmistamiseks, mis on ette nähtud kesknärvisüsteemi häirete ravimiseks, ja farmatseutiline kompositsioon
EP0769903A4 (fr)	1999-10-27	Gene pour synthase d'oxyde nitrique inductible pour le traitement de maladies
EP1778335A4 (fr)	2008-07-09	Dispositifs implantables et procedes d'administration de medicaments et d'autres substances pour le traitement de la sinusite et d'autres troubles
FR2777192B1 (fr)	2001-06-15	Composition a base d'herbes pour le traitement des maladies pulmonaires chroniques obstructives, des bronchites et des troubles respiratoires et procede de preparation de celle-ci
NO963568D0 (no)	1996-08-27	Farmasöytisk preparat for behandling av blodkoagulasjonssykdommer, fremgangsmåter for fremstilling av dette og dets anvendelse
MA29084B1 (fr)	2007-12-03	Derives d'indenyle et leur utilisation dans le traitement de troubles neurologiques
MA26658A1 (fr)	2004-12-20	Derivés de valérohydrazine, procédé pour les préparer, médicament pour le traitement des maladies inflammatoires et auto-immunes les contenant, et leur utilisation pour préparer un tel médicament
DZ3027A1 (fr)	2004-03-27	Composés et procédés pour le traitement de l'asthme, de l'allergie et des troubles inflammatoires.
EP0270690A4 (fr)	1989-07-06	Medicament pour le traitement et la prophylaxie de maladies du rein et du foie.
FR2792835B3 (fr)	2001-05-25	Utilisation du saredutant pour la preparation de medicaments utiles dans le traitement ou la prevention de l'ensemble des troubles de l'humeur, des troubles de l'adaptation ou des troubles mixtes anxiete-depression
IL119459A0 (en)	1997-01-10	Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases
EP1469852A4 (fr)	2009-12-02	Donneurs de monoxyde d'azote pour le traitement de maladies et de blessures
FR2792837B1 (fr)	2001-07-13	Medicaments utiles pour le traitement des troubles de la regulation de la masse adipeuse et des maladies associees aux troubles de la production de leptine
MA26683A1 (fr)	2004-12-20	Derives de piperidine, procede pour leur preparation, medicaments les contenant et leur utilisation dans le traitement de troubles neurologiques et physiologiques
FR2619713B1 (fr)	1990-08-31	Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement des troubles du sommeil et de la depression
FR2792199B3 (fr)	2001-05-18	Utilisation de l'osanetant pour la preparation de medicaments utiles dans le traitement des troubles de l'humeur
EP1583829A4 (fr)	2007-08-01	Procedes pour le traitement de troubles de l'alimentation ou de l'assimilation du glucose et pour la modification du metabolisme et l'identification de reactifs therapeutiques en liaison avec ces troubles
EP0990441A4 (fr)	2002-10-16	Medicament pour le traitement de la nephropathie diabetique
ITRM960827A0 (it)	1996-12-03	Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi
DE69626312D1 (de)	2003-03-27	Medikament zur linderung von schmerzen und zur förderung der entfernung von konkrementen bei urolithiasis
FR2774289B1 (fr)	2002-05-24	Medicament pour le traitement des dereglements de l'apoptose
MA26652A1 (fr)	2004-12-20	Compositions pharmaceutiques mixtes pour le traitement de la faiblesse musculosquelettique, et procede pour leur preparation

Legal Events

Date	Code	Title	Description
2015-03-19	PLFP	Fee payment	Year of fee payment: 17
2016-03-23	PLFP	Fee payment	Year of fee payment: 18
2017-03-22	PLFP	Fee payment	Year of fee payment: 19
2018-04-26	PLFP	Fee payment	Year of fee payment: 20